Bottom line
What is IBRSX's expense ratio?
IBRSX's expense ratio is 0.84%, or about $84 a year on every $10,000 invested. That is more expensive than 59% of buffer / defined outcome funds we track (median 0.74%). Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Apr 24, 2026
IBRSX fee table
| Net expense ratio | 0.84% |
|---|---|
| Gross expense ratio | 0.91% |
| Management fee | 0.55% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.11% |
| Fee waiver / reimbursement | -0.07% |
Source: Fund prospectus fee table, filed Apr 24, 2026
What IBRSX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| IBRSX | $86 | $283 | $497 | $1,113 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.84% expense ratio costs roughly $47,200 in lost growth, versus about $41,900 for the median buffer / defined outcome fund (0.74%).